董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Brian S. John | 男 | Chairman of the Board and Chief Executive Officer | 53 | 未披露 | 未持股 | 2022-12-30 |
| Nancy Torres Kaufman | 女 | Director | 42 | 未披露 | 未持股 | 2022-12-30 |
| N. Adele Hogan | 女 | Director | 60 | 未披露 | 未持股 | 2022-12-30 |
| Hans Haywood | 男 | Director | 54 | 未披露 | 未持股 | 2022-12-30 |
| Robert D. Allison | 男 | Director | 46 | 未披露 | 未持股 | 2022-12-30 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Brian S. John | 男 | Chairman of the Board and Chief Executive Officer | 53 | 未披露 | 未持股 | 2022-12-30 |
| Ke Li | 男 | Chief Financial Officer | 33 | 未披露 | 未持股 | 2022-12-30 |
董事简历
中英对照 | 中文 | 英文- Brian S. John
-
Brian S.John是我们的创始人之一，自2018年10月以来一直担任我们的首席执行官。在过去的20年里，Brian一直是全球公司的投资者和顾问。2021年10月5日，他被任命为公司的首席投资官。他是Caro Partners，LLC的创始人，这是一家金融咨询公司，专门协助新兴成长型公司，主要是在1亿美元以下的领域，并在过去25年中与数十个国家的数百家公司合作。John先生是Teeka Tan Products Inc.的首席执行官，这是一家太阳护理公司，他于2004年共同创立，后来被出售。他也是Els Center of Excellence（佛罗里达州朱庇特的自闭症儿童学校）学习中心的董事会成员。2015年8月，John先生根据《美国破产法》第7章，自愿向佛罗里达州南区美国破产法院的案件#15-24036-PGH申请个人破产。债务人John先生于2016年2月19日被解除债务，该事项于2017年4月终止。诉讼程序中没有欺诈指控。
Brian S. John is one of Jupiter Wellness, Inc. founders and has served as Jupiter Wellness, Inc. Chief Executive Officer since October 2018. For the past 20 years, Brian has been an investor and advisor to companies around the globe. He is the founder of Caro Partners, LLC, a financial consulting firm specializing in assisting emerging growth companies primarily in the sub- $100 million space, and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John was the Chief Executive Officer of Teeka Tan Products Inc., a sun care company he co-founded in 2004 and later sold. He also serves on the board of directors of The Learning Center at the Els Center of Excellence-a school for children with autism in Jupiter, Florida. In August 2015 Mr. John voluntarily petitioned the United States Bankruptcy Court in the Southern District of Florida for personal bankruptcy under Chapter 7 of the United States bankruptcy Code. The debtor, Mr. John, was discharged in February 19 2016 and the matter was terminated in April 2017. There were no allegations of fraud made in the proceedings. - Brian S.John是我们的创始人之一，自2018年10月以来一直担任我们的首席执行官。在过去的20年里，Brian一直是全球公司的投资者和顾问。2021年10月5日，他被任命为公司的首席投资官。他是Caro Partners，LLC的创始人，这是一家金融咨询公司，专门协助新兴成长型公司，主要是在1亿美元以下的领域，并在过去25年中与数十个国家的数百家公司合作。John先生是Teeka Tan Products Inc.的首席执行官，这是一家太阳护理公司，他于2004年共同创立，后来被出售。他也是Els Center of Excellence（佛罗里达州朱庇特的自闭症儿童学校）学习中心的董事会成员。2015年8月，John先生根据《美国破产法》第7章，自愿向佛罗里达州南区美国破产法院的案件#15-24036-PGH申请个人破产。债务人John先生于2016年2月19日被解除债务，该事项于2017年4月终止。诉讼程序中没有欺诈指控。
- Brian S. John is one of Jupiter Wellness, Inc. founders and has served as Jupiter Wellness, Inc. Chief Executive Officer since October 2018. For the past 20 years, Brian has been an investor and advisor to companies around the globe. He is the founder of Caro Partners, LLC, a financial consulting firm specializing in assisting emerging growth companies primarily in the sub- $100 million space, and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John was the Chief Executive Officer of Teeka Tan Products Inc., a sun care company he co-founded in 2004 and later sold. He also serves on the board of directors of The Learning Center at the Els Center of Excellence-a school for children with autism in Jupiter, Florida. In August 2015 Mr. John voluntarily petitioned the United States Bankruptcy Court in the Southern District of Florida for personal bankruptcy under Chapter 7 of the United States bankruptcy Code. The debtor, Mr. John, was discharged in February 19 2016 and the matter was terminated in April 2017. There were no allegations of fraud made in the proceedings.
- Nancy Torres Kaufman
-
Nancy Torres Kaufman自2021年1月起担任我们的董事之一。Kaufman女士是Beacon Capital LLC的董事长兼首席执行官，这是一家纽约的家族办公室，最近搬到了佛罗里达州的朱庇特。Kaufman女士于2010年正式创立了Beacon Capital，作为她的家族办公室和投资平台，专注于全球生命科学业务的投资。2003年，Nancy创办了一家名为Wall St.Mortgage的抵押贷款代理贷款公司，这是一家第一和第二留置权对应的贷款人和经纪公司，她于2006年将其出售给Countrywide。2004年，她加入了投资银行精品公司Violy&Co，并日益专注于她的第一个爱好，生命科学。Nancy是一位土生土长的古巴裔企业家，致力于将风险影响慈善事业带入生命科学和医疗保健领域。1994年，14岁的她独自一人离开古巴前往美国。1999年，南希获得了圣伊丽莎白学院的全额学术奖学金，其中包括UMDNJ的一个加速医学项目，该项目的学士学位是生物学，辅修化学。2020年，南希还进入了耶鲁大学管理学院的女性领导力项目。
Nancy Torres Kaufman has served as one of Jupiter Wellness, Inc. directors since January 2021. Ms. Kaufman is the Chairman and CEO of Beacon Capital LLC, a New York family office, recently relocated to Jupiter, Florida. Ms. Kaufman officially founded Beacon Capital as her family office and investment platform in 2010 with a focus on investing in life sciences businesses globally. In 2003 Nancy started a mortgage correspondent lending company called Wall St. Mortgage, a first and second lien corresponding lender and brokerage company which book and operations she sold to Countrywide in 2006. In 2004 she joined the investment banking boutique Violy & Co and focused increasingly on her first passion, life sciences. Nancy is a Cuban born and raised entrepreneur focused on bringing venture impact philanthropy into the life science and healthcare space. She left Cuba 1994 for the Jupiter Wellness, Inc. unaccompanied as a 14-years old. In 1999 Nancy was awarded a full academic scholarship to the College of St. Elizabeth, consisting of an accelerated medical program with UMDNJ for a Bachelor of Science Major in Biology with a Chemistry minor. Nancy also entered the Women's Leadership Program at Yale School of Management in 2020. - Nancy Torres Kaufman自2021年1月起担任我们的董事之一。Kaufman女士是Beacon Capital LLC的董事长兼首席执行官，这是一家纽约的家族办公室，最近搬到了佛罗里达州的朱庇特。Kaufman女士于2010年正式创立了Beacon Capital，作为她的家族办公室和投资平台，专注于全球生命科学业务的投资。2003年，Nancy创办了一家名为Wall St.Mortgage的抵押贷款代理贷款公司，这是一家第一和第二留置权对应的贷款人和经纪公司，她于2006年将其出售给Countrywide。2004年，她加入了投资银行精品公司Violy&Co，并日益专注于她的第一个爱好，生命科学。Nancy是一位土生土长的古巴裔企业家，致力于将风险影响慈善事业带入生命科学和医疗保健领域。1994年，14岁的她独自一人离开古巴前往美国。1999年，南希获得了圣伊丽莎白学院的全额学术奖学金，其中包括UMDNJ的一个加速医学项目，该项目的学士学位是生物学，辅修化学。2020年，南希还进入了耶鲁大学管理学院的女性领导力项目。
- Nancy Torres Kaufman has served as one of Jupiter Wellness, Inc. directors since January 2021. Ms. Kaufman is the Chairman and CEO of Beacon Capital LLC, a New York family office, recently relocated to Jupiter, Florida. Ms. Kaufman officially founded Beacon Capital as her family office and investment platform in 2010 with a focus on investing in life sciences businesses globally. In 2003 Nancy started a mortgage correspondent lending company called Wall St. Mortgage, a first and second lien corresponding lender and brokerage company which book and operations she sold to Countrywide in 2006. In 2004 she joined the investment banking boutique Violy & Co and focused increasingly on her first passion, life sciences. Nancy is a Cuban born and raised entrepreneur focused on bringing venture impact philanthropy into the life science and healthcare space. She left Cuba 1994 for the Jupiter Wellness, Inc. unaccompanied as a 14-years old. In 1999 Nancy was awarded a full academic scholarship to the College of St. Elizabeth, consisting of an accelerated medical program with UMDNJ for a Bachelor of Science Major in Biology with a Chemistry minor. Nancy also entered the Women's Leadership Program at Yale School of Management in 2020.
- N. Adele Hogan
-
N.Adele Hogan自2021年9月起担任我们的董事，自2021年3月起担任Lucosky Bookman LLP公司和证券业务集团的合伙人兼联席主席。从2012年到2021年3月，她是Hogan Law Associates PLLC的合伙人。2016年，霍根女士还担任德意志银行的董事。从2009年到2012年，她是Cadwalader，Wickersham&Taft LLP的法律顾问；从2009年到2012年，她是White&Case LLP的合伙人，从2005年到2007年，她是Linklaters LLP的合伙人。从1995年到2005年，Hogan女士是Cravath Swaine&Moore LLP的高级律师，Hogan女士于1985年获得康奈尔大学法学院的法学博士学位，并于1982年获得康奈尔大学的学士学位。
N. Adele Hogan has been our director since September 2021 and has been a Partner and Co-Chair of the Corporate and Securities Practice Group at Lucosky Bookman LLP since March 2021. From 2012 to March 2021 she was a Partner at Hogan Law Associates PLLC. During 2016 Ms. Hogan was also a Director at Deutsche Bank. From 2009 to 2012she was Counsel at Cadwalader, Wickersham & Taft LLP; from 2009 to 2012 she was a Partner at White & Case LLP;, and from 2005 to 2007 she was a Partner at Linklaters LLP. From 1995 to 2005 Ms. Hogan was a Senior Attorney at Cravath Swaine & Moore LLP Ms. Hogan received a J.D. from Cornell University Law School in 1985 and a B.A. from Cornell University in 1982. - N.Adele Hogan自2021年9月起担任我们的董事，自2021年3月起担任Lucosky Bookman LLP公司和证券业务集团的合伙人兼联席主席。从2012年到2021年3月，她是Hogan Law Associates PLLC的合伙人。2016年，霍根女士还担任德意志银行的董事。从2009年到2012年，她是Cadwalader，Wickersham&Taft LLP的法律顾问；从2009年到2012年，她是White&Case LLP的合伙人，从2005年到2007年，她是Linklaters LLP的合伙人。从1995年到2005年，Hogan女士是Cravath Swaine&Moore LLP的高级律师，Hogan女士于1985年获得康奈尔大学法学院的法学博士学位，并于1982年获得康奈尔大学的学士学位。
- N. Adele Hogan has been our director since September 2021 and has been a Partner and Co-Chair of the Corporate and Securities Practice Group at Lucosky Bookman LLP since March 2021. From 2012 to March 2021 she was a Partner at Hogan Law Associates PLLC. During 2016 Ms. Hogan was also a Director at Deutsche Bank. From 2009 to 2012she was Counsel at Cadwalader, Wickersham & Taft LLP; from 2009 to 2012 she was a Partner at White & Case LLP;, and from 2005 to 2007 she was a Partner at Linklaters LLP. From 1995 to 2005 Ms. Hogan was a Senior Attorney at Cravath Swaine & Moore LLP Ms. Hogan received a J.D. from Cornell University Law School in 1985 and a B.A. from Cornell University in 1982.
- Hans Haywood
-
Hans Haywood自2021年9月以来一直担任我们的董事，目前是HKA Capital Advisors的负责人，该公司是他于2010年创立的提供咨询服务和开发专有交易算法的平台。2011年5月至2018年4月，Haywood先生担任总部位于苏黎世的家族办公室/私募股权基金Tempest Capital AG的联席首席投资官兼董事，负责构建和进行技术和自然资源行业的激进投资。Haywood从2009年5月到2011年3月担任Panda Global Advisors首席投资官，这是一家新兴市场导向的全球宏观基金，专注于流动资产、主权信贷、利率、外汇、股票和大宗商品，他于2011年创立该公司。从2005年7月到2007年12月，他曾担任Sailfish Capital Partners公司（多策略基金）的合伙人兼高级投资组合经理，在那里他共同创立并管理该基金的全球新兴市场战略。从1997年12月到2005年6月，他曾担任Credit Suisse公司的董事总经理，在那里他曾管理公司的专有信贷投资组合，并共同负责公司的面向客户的交易平台的创建。Haywood先生于1990年获得伦敦大学帝国理工学院的化学工程硕士学位。
Hans Haywood has been our director since September 2021 and is currently a principal of HKA Capital Advisors, a platform from which to offer consulting services and develop proprietary trading algorithms, which he founded in 2010. From May 2011 to April 2018 Mr. Haywood was the Co-Chief Investment Officer and a Director of Tempest Capital AG, a Zurich-based family office/private equity fund, responsible for structuring and making activist investments in the technology and natural resource sectors. From May 2009 to March 2011 Mr. Haywood was the Chief Investment Officer of Panda Global Advisors, an emerging markets oriented Global Macro fund with a focus on liquid assets, sovereign credit, interest rates, foreign exchange, equity and commodities, which he founded in 2011. From July 2005 to December 2007 Mr. Haywood was a Partner and Senior Portfolio Manager for Sailfish Capital Partners, a multi-strategy fund, where he co-founded and managed the fund's global Emerging Markets strategy. From December 1997 to June 2005 he was a Managing director at Credit Suisse where he managed the firm's proprietary credit portfolio and was jointly responsible for the creation of the firm's customer-oriented trading platform. Mr. Haywood received a master's degree in Chemical Engineering from Imperial College, University of London in 1990. - Hans Haywood自2021年9月以来一直担任我们的董事，目前是HKA Capital Advisors的负责人，该公司是他于2010年创立的提供咨询服务和开发专有交易算法的平台。2011年5月至2018年4月，Haywood先生担任总部位于苏黎世的家族办公室/私募股权基金Tempest Capital AG的联席首席投资官兼董事，负责构建和进行技术和自然资源行业的激进投资。Haywood从2009年5月到2011年3月担任Panda Global Advisors首席投资官，这是一家新兴市场导向的全球宏观基金，专注于流动资产、主权信贷、利率、外汇、股票和大宗商品，他于2011年创立该公司。从2005年7月到2007年12月，他曾担任Sailfish Capital Partners公司（多策略基金）的合伙人兼高级投资组合经理，在那里他共同创立并管理该基金的全球新兴市场战略。从1997年12月到2005年6月，他曾担任Credit Suisse公司的董事总经理，在那里他曾管理公司的专有信贷投资组合，并共同负责公司的面向客户的交易平台的创建。Haywood先生于1990年获得伦敦大学帝国理工学院的化学工程硕士学位。
- Hans Haywood has been our director since September 2021 and is currently a principal of HKA Capital Advisors, a platform from which to offer consulting services and develop proprietary trading algorithms, which he founded in 2010. From May 2011 to April 2018 Mr. Haywood was the Co-Chief Investment Officer and a Director of Tempest Capital AG, a Zurich-based family office/private equity fund, responsible for structuring and making activist investments in the technology and natural resource sectors. From May 2009 to March 2011 Mr. Haywood was the Chief Investment Officer of Panda Global Advisors, an emerging markets oriented Global Macro fund with a focus on liquid assets, sovereign credit, interest rates, foreign exchange, equity and commodities, which he founded in 2011. From July 2005 to December 2007 Mr. Haywood was a Partner and Senior Portfolio Manager for Sailfish Capital Partners, a multi-strategy fund, where he co-founded and managed the fund's global Emerging Markets strategy. From December 1997 to June 2005 he was a Managing director at Credit Suisse where he managed the firm's proprietary credit portfolio and was jointly responsible for the creation of the firm's customer-oriented trading platform. Mr. Haywood received a master's degree in Chemical Engineering from Imperial College, University of London in 1990.
- Robert D. Allison
-
Robert D.Allison自2021年9月起担任我们的董事，并在美国国立卫生研究院，美国疾病控制中心，世界卫生组织和美国海军领导临床研究和公共卫生计划方面拥有超过15年的经验。自2021年2月以来，他一直是美国食品药品监督管理局新药办公室，药物评估和研究中心的抗病毒药物部门的医学审查员。自2020年10月以来，他一直担任Quality Management Consultants，LLC的负责人，领导医疗保健行业的质量改进研究解决方案。从2019年1月至2020年2月，他是CDC的医学流行病学家，支持消除肝炎，作为与世界卫生组织和全球新冠肺炎应对措施的联络人。从2019年1月至2020年1月，他担任Sendero Health Plans，Inc.的首席医疗官，从2016年1月至2019年1月，他担任NIH临床中心传染病部门负责人兼研究副主任。自2017年3月以来，Allison博士一直担任约翰霍普金斯大学彭博公共卫生学院卫生政策与管理部的兼职教员。他于1997年在新泽西学院获得化学学士学位，于2000年在南佛罗里达大学获得传染病流行病学硕士学位，并于2006年在佛罗里达州立大学医学院获得医学博士学位。从2006年到2008年，他直接在Harvey J.Alter博士（2020年诺贝尔医学奖）的指导下接受博士后培训。他于2010年在圣地亚哥海军医疗中心完成了内科医学培训，并于2014年在约翰霍普金斯大学完成了预防医学培训。Allison博士自2006年以来一直是NIH许多临床研究的首席或副研究员，撰写了超过25篇同行评审的出版物，并拥有2项实验室开发病原体检测芯片的专利。
Robert D. Allison has been our director since September 2021 and has over 15 years of experience leading clinical research and public health programs for the National Institutes of Health NIH, the Centers for Disease Control (CDC), the World Health Organization (WHO) and the U.S. Navy. Since February 2021 he has been a medical reviewer in the Division of Antivirals, Office of New Drugs, Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. He has served as the Principal of Quality Management Consultants, LLC, since October 2020 where he leads quality improvement research solutions for the healthcare industry. From January 2019 to February 2020 he was a medical epidemiologist for the CDC supporting hepatitis elimination as a liaison to WHO and COVID-19 response globally. From January 2019 to January 2020 he was the Chief Medical Officer of Sendero Health Plans, Inc., and from January 2016 to January 2019 he was the Chief of the Infectious Diseases Section and Associate Director for Research in the NIH Clinical Center. Dr. Allison has served as an adjunct faculty member in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health since March 2017. He received a B.S. in Chemistry in 1997 at the College Of New Jersey, an M.P.H. in infectious diseases epidemiology at the University of South Florida in 2000 and an M.D. from the Florida State University College of Medicine in 2006. From 2006 to 2008 he trained directly under Dr. Harvey J. Alter (Nobel Prize in Medicine, 2020) as a postdoctoral fellow. He completed training in internal medicine at the Naval Medical Center San Diego in 2010 and in preventive medicine at Johns Hopkins in 2014. Dr. Allison has been principal or associate investigator on numerous clinical research studies at the NIH since 2006 has authored over 25 peer-reviewed publications and has 2 patents for his laboratory's development of a pathogen detection chip. - Robert D.Allison自2021年9月起担任我们的董事，并在美国国立卫生研究院，美国疾病控制中心，世界卫生组织和美国海军领导临床研究和公共卫生计划方面拥有超过15年的经验。自2021年2月以来，他一直是美国食品药品监督管理局新药办公室，药物评估和研究中心的抗病毒药物部门的医学审查员。自2020年10月以来，他一直担任Quality Management Consultants，LLC的负责人，领导医疗保健行业的质量改进研究解决方案。从2019年1月至2020年2月，他是CDC的医学流行病学家，支持消除肝炎，作为与世界卫生组织和全球新冠肺炎应对措施的联络人。从2019年1月至2020年1月，他担任Sendero Health Plans，Inc.的首席医疗官，从2016年1月至2019年1月，他担任NIH临床中心传染病部门负责人兼研究副主任。自2017年3月以来，Allison博士一直担任约翰霍普金斯大学彭博公共卫生学院卫生政策与管理部的兼职教员。他于1997年在新泽西学院获得化学学士学位，于2000年在南佛罗里达大学获得传染病流行病学硕士学位，并于2006年在佛罗里达州立大学医学院获得医学博士学位。从2006年到2008年，他直接在Harvey J.Alter博士（2020年诺贝尔医学奖）的指导下接受博士后培训。他于2010年在圣地亚哥海军医疗中心完成了内科医学培训，并于2014年在约翰霍普金斯大学完成了预防医学培训。Allison博士自2006年以来一直是NIH许多临床研究的首席或副研究员，撰写了超过25篇同行评审的出版物，并拥有2项实验室开发病原体检测芯片的专利。
- Robert D. Allison has been our director since September 2021 and has over 15 years of experience leading clinical research and public health programs for the National Institutes of Health NIH, the Centers for Disease Control (CDC), the World Health Organization (WHO) and the U.S. Navy. Since February 2021 he has been a medical reviewer in the Division of Antivirals, Office of New Drugs, Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. He has served as the Principal of Quality Management Consultants, LLC, since October 2020 where he leads quality improvement research solutions for the healthcare industry. From January 2019 to February 2020 he was a medical epidemiologist for the CDC supporting hepatitis elimination as a liaison to WHO and COVID-19 response globally. From January 2019 to January 2020 he was the Chief Medical Officer of Sendero Health Plans, Inc., and from January 2016 to January 2019 he was the Chief of the Infectious Diseases Section and Associate Director for Research in the NIH Clinical Center. Dr. Allison has served as an adjunct faculty member in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health since March 2017. He received a B.S. in Chemistry in 1997 at the College Of New Jersey, an M.P.H. in infectious diseases epidemiology at the University of South Florida in 2000 and an M.D. from the Florida State University College of Medicine in 2006. From 2006 to 2008 he trained directly under Dr. Harvey J. Alter (Nobel Prize in Medicine, 2020) as a postdoctoral fellow. He completed training in internal medicine at the Naval Medical Center San Diego in 2010 and in preventive medicine at Johns Hopkins in 2014. Dr. Allison has been principal or associate investigator on numerous clinical research studies at the NIH since 2006 has authored over 25 peer-reviewed publications and has 2 patents for his laboratory's development of a pathogen detection chip.
高管简历
中英对照 | 中文 | 英文- Brian S. John
Brian S.John是我们的创始人之一，自2018年10月以来一直担任我们的首席执行官。在过去的20年里，Brian一直是全球公司的投资者和顾问。2021年10月5日，他被任命为公司的首席投资官。他是Caro Partners，LLC的创始人，这是一家金融咨询公司，专门协助新兴成长型公司，主要是在1亿美元以下的领域，并在过去25年中与数十个国家的数百家公司合作。John先生是Teeka Tan Products Inc.的首席执行官，这是一家太阳护理公司，他于2004年共同创立，后来被出售。他也是Els Center of Excellence（佛罗里达州朱庇特的自闭症儿童学校）学习中心的董事会成员。2015年8月，John先生根据《美国破产法》第7章，自愿向佛罗里达州南区美国破产法院的案件#15-24036-PGH申请个人破产。债务人John先生于2016年2月19日被解除债务，该事项于2017年4月终止。诉讼程序中没有欺诈指控。
Brian S. John is one of Jupiter Wellness, Inc. founders and has served as Jupiter Wellness, Inc. Chief Executive Officer since October 2018. For the past 20 years, Brian has been an investor and advisor to companies around the globe. He is the founder of Caro Partners, LLC, a financial consulting firm specializing in assisting emerging growth companies primarily in the sub- $100 million space, and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John was the Chief Executive Officer of Teeka Tan Products Inc., a sun care company he co-founded in 2004 and later sold. He also serves on the board of directors of The Learning Center at the Els Center of Excellence-a school for children with autism in Jupiter, Florida. In August 2015 Mr. John voluntarily petitioned the United States Bankruptcy Court in the Southern District of Florida for personal bankruptcy under Chapter 7 of the United States bankruptcy Code. The debtor, Mr. John, was discharged in February 19 2016 and the matter was terminated in April 2017. There were no allegations of fraud made in the proceedings.- Brian S.John是我们的创始人之一，自2018年10月以来一直担任我们的首席执行官。在过去的20年里，Brian一直是全球公司的投资者和顾问。2021年10月5日，他被任命为公司的首席投资官。他是Caro Partners，LLC的创始人，这是一家金融咨询公司，专门协助新兴成长型公司，主要是在1亿美元以下的领域，并在过去25年中与数十个国家的数百家公司合作。John先生是Teeka Tan Products Inc.的首席执行官，这是一家太阳护理公司，他于2004年共同创立，后来被出售。他也是Els Center of Excellence（佛罗里达州朱庇特的自闭症儿童学校）学习中心的董事会成员。2015年8月，John先生根据《美国破产法》第7章，自愿向佛罗里达州南区美国破产法院的案件#15-24036-PGH申请个人破产。债务人John先生于2016年2月19日被解除债务，该事项于2017年4月终止。诉讼程序中没有欺诈指控。
- Brian S. John is one of Jupiter Wellness, Inc. founders and has served as Jupiter Wellness, Inc. Chief Executive Officer since October 2018. For the past 20 years, Brian has been an investor and advisor to companies around the globe. He is the founder of Caro Partners, LLC, a financial consulting firm specializing in assisting emerging growth companies primarily in the sub- $100 million space, and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John was the Chief Executive Officer of Teeka Tan Products Inc., a sun care company he co-founded in 2004 and later sold. He also serves on the board of directors of The Learning Center at the Els Center of Excellence-a school for children with autism in Jupiter, Florida. In August 2015 Mr. John voluntarily petitioned the United States Bankruptcy Court in the Southern District of Florida for personal bankruptcy under Chapter 7 of the United States bankruptcy Code. The debtor, Mr. John, was discharged in February 19 2016 and the matter was terminated in April 2017. There were no allegations of fraud made in the proceedings.
- Ke Li
Ke Li自2021年9月起担任我们的首席财务官，自2021年11月起担任我们的秘书。2014年9月以来，Ke Li一直担任L&L CPAS，PA的管理合伙人，这是一家PCAOB注册的公共会计师事务所，他是该公司的联合创始人，该公司专注于上市公司的领先综合年度审计，审查财务报表，并评估重要的会计判断。此外，自2013年9月起，Li先生担任Greentree Financial Group Inc.的分析师，该公司为上市公司提供财务和会计咨询服务。李先生在上市公司拥有10多年的审计，财务报表准备和合规，财务分析，风险评估，内部控制和业务合并的实践经验。李先生是北卡罗来纳州和伊利诺伊州的注册会计师。
Ke Li has been our Chief Financial Officer since September 2021 and our Secretary since November 2021. Since September 2014 Ke Li has been the Managing Partner of L&L CPAS, PA, a PCAOB registered public accounting firm of which he was a Co-Founder, which focuses on leading integrated annual audits of publicly traded companies, reviewing the financial statements, and evaluating significant accounting judgements. In addition, since September 2013 Mr. Li has served as an analyst at Greentree Financial Group Inc. which provides financial and accounting advisory services to public companies. Mr. Li has 10+ years of practical experience in publicly traded companies by audits, financial statements preparation and compliance, financial analysis, risk assessments, internal control and business combination. Mr. Li is Certified Public Accountant in North Carolina and Illinois.- Ke Li自2021年9月起担任我们的首席财务官，自2021年11月起担任我们的秘书。2014年9月以来，Ke Li一直担任L&L CPAS，PA的管理合伙人，这是一家PCAOB注册的公共会计师事务所，他是该公司的联合创始人，该公司专注于上市公司的领先综合年度审计，审查财务报表，并评估重要的会计判断。此外，自2013年9月起，Li先生担任Greentree Financial Group Inc.的分析师，该公司为上市公司提供财务和会计咨询服务。李先生在上市公司拥有10多年的审计，财务报表准备和合规，财务分析，风险评估，内部控制和业务合并的实践经验。李先生是北卡罗来纳州和伊利诺伊州的注册会计师。
- Ke Li has been our Chief Financial Officer since September 2021 and our Secretary since November 2021. Since September 2014 Ke Li has been the Managing Partner of L&L CPAS, PA, a PCAOB registered public accounting firm of which he was a Co-Founder, which focuses on leading integrated annual audits of publicly traded companies, reviewing the financial statements, and evaluating significant accounting judgements. In addition, since September 2013 Mr. Li has served as an analyst at Greentree Financial Group Inc. which provides financial and accounting advisory services to public companies. Mr. Li has 10+ years of practical experience in publicly traded companies by audits, financial statements preparation and compliance, financial analysis, risk assessments, internal control and business combination. Mr. Li is Certified Public Accountant in North Carolina and Illinois.